{
    "8800": {
        "explanation_text": "Type 2 diabetes mellitus with other diabetic kidney complication.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus for the past 10 years, with well-controlled blood sugar levels through lifestyle modifications and metformin.The patient presented with increased urinary frequency, fatigue, and pedal edema.Laboratory tests revealed elevated serum creatinine levels and microalbuminuria, indicating kidney involvement in the diabetes mellitus.Type 2 diabetes mellitus with other diabetic kidney complications. Verbatim_EHR_quote_justifying_the_code: 'The patient presents with Type 2 diabetes mellitus with evidence of kidney involvement, as indicated by elevated serum creatinine levels and microalbuminuria.'The physician observed signs of diabetic nephropathy during the physical examination, with no indications of chronic kidney disease beyond the complications related to diabetes.The patient was started on an ACE inhibitor for renal protection, along with dietary counseling and adjustments to the diabetes management regimen.The patient responded well to treatment and was discharged with recommendations for regular follow-up visits with both the endocrinologist and nephrologist.55FemaleCaucasian"
    },
    "8801": {
        "explanation_text": "Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus.The patient presents with blurred vision and eye pain.Ophthalmologic examination shows signs of diabetic retinopathy with macular edema.Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema (E11311).The patient's symptoms and diagnostic tests confirm the presence of macular edema in the setting of diabetic retinopathy.The patient is advised to control blood sugar levels tightly and is referred to an ophthalmologist for further management of the retinopathy.The patient is stable and discharged with instructions to follow up with the ophthalmologist for ongoing care.55FemaleCaucasian"
    },
    "8802": {
        "explanation_text": "Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and regular follow-ups with the endocrinologist for glycemic control.The patient reports no specific visual disturbances or changes in vision. Denies any pain, redness, or discharge from the eyes.Recent fundoscopic examination shows signs of diabetic retinopathy without macular edema.Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema.Patient's blood glucose levels have been relatively stable. Fundoscopy revealed characteristic findings of diabetic retinopathy but no macular edema.Prescribed oral hypoglycemic agents for diabetes management. Advised regular ophthalmic follow-ups for monitoring of retinopathy.The patient was discharged in stable condition with instructions to continue medications and follow-up with both endocrinology and ophthalmology clinics.55FemaleCaucasian"
    },
    "8803": {
        "explanation_text": "Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and has been managing the condition with lifestyle modifications and oral antidiabetic medications.The patient is asymptomatic for any visual disturbances, such as blurred vision or floaters. No complaints of eye pain or redness.Recent ophthalmologic examination revealed mild nonproliferative diabetic retinopathy without macular edema in both eyes.Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral. Verbatim EHR quote justifying the code: 'Recent ophthalmologic examination revealed mild nonproliferative diabetic retinopathy without macular edema in both eyes.'Patient's blood glucose levels have been relatively stable, and there are no signs of systemic complications related to diabetes. Advised the patient on the importance of regular eye examinations to monitor the diabetic retinopathy.Continuation of current antidiabetic medication regimen. Referral to an ophthalmologist for regular follow-up and monitoring of the diabetic retinopathy.58FemaleCaucasian"
    },
    "8804": {
        "explanation_text": "Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus and regular follow-ups with an ophthalmologist for diabetic retinopathy screening.The patient is asymptomatic for any visual disturbances, has no complaints of eye pain, and denies any recent changes in vision.Recent fundoscopic examination results indicate mild nonproliferative diabetic retinopathy without macular edema in the unspecified eye.Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema (E113299).The patient's blood glucose levels are well-controlled with oral antidiabetic medication. Fundoscopy revealed microaneurysms and retinal hemorrhages consistent with mild nonproliferative diabetic retinopathy.Continuation of current oral antidiabetic medication regimen. Referral to the ophthalmologist for regular diabetic retinopathy monitoring.The patient was educated on the importance of glycemic control and regular ophthalmologic follow-ups. Discharged in stable condition.58FemaleCaucasian"
    },
    "8805": {
        "explanation_text": "Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and regular ophthalmology check-ups due to diabetic retinopathy.The patient reports mild blurriness in vision but denies any vision loss or distortion. No complaints of eye pain, redness, or floaters.Ophthalmologic exam revealed bilateral moderate nonproliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye. Verbatim_EHR_quote_justifying_the_code: The ophthalmologic exam confirmed the presence of moderate nonproliferative diabetic retinopathy without macular edema, supporting the assignment of E113399.Patient's blood glucose levels are well-controlled with current medication regimen. Advised on diabetic diet and regular eye examinations.Prescribed diabetic management medications and scheduled a follow-up ophthalmology appointment in three months.The patient was discharged in stable condition with instructions to monitor blood sugar levels closely and attend all scheduled follow-up appointments.58FemaleCaucasian"
    },
    "8806": {
        "explanation_text": "Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and regular ophthalmic check-ups due to diabetic retinopathy.The patient reports blurred vision and occasional floaters in the vision field.Ophthalmologic examination revealed severe nonproliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye. Verbatim EHR quote justifying the code: 'Ophthalmologic examination confirmed severe nonproliferative diabetic retinopathy without macular edema.'The patient is at high risk for vision loss due to the severity of the retinopathy. Close monitoring and prompt intervention are crucial.Treatment includes optimizing blood glucose control, referral to a retinal specialist for further evaluation, and potential laser therapy.The patient was discharged with a follow-up appointment in two weeks to assess treatment response and adjust the management plan if needed.58FemaleCaucasian"
    },
    "8807": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus.The patient complains of blurred vision, floaters, and difficulty seeing at night.Fundoscopic examination shows neovascularization, intraretinal hemorrhages, and macular edema in both eyes.Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral. Verbatim_EHR_quote_justifying_the_code: 'Fundoscopic examination reveals neovascularization, intraretinal hemorrhages, and macular edema in both eyes.'Patient's blood glucose levels are well controlled with current medication.Initiated laser photocoagulation therapy for proliferative diabetic retinopathy and intravitreal injections for macular edema.Patient discharged in stable condition with scheduled follow-up appointments for continued ophthalmologic care.55FemaleCaucasian"
    },
    "8808": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus for the past 10 years. The patient has been compliant with medications and regular follow-ups.The patient complains of blurred vision in the right eye, especially in low light conditions. No symptoms of macular edema such as central vision loss or distortion are reported.Ophthalmologic examination reveals neovascularization of the optic disc and elsewhere in the retina of the right eye, characteristic of proliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye. Verbatim EHR quote justifying the code: 'Ophthalmologic examination reveals neovascularization of the optic disc and elsewhere in the retina of the right eye, characteristic of proliferative diabetic retinopathy without macular edema.'Fundoscopic examination shows new vessels at the disc and elsewhere in the retina of the right eye. No signs of macular edema are noted. The patient is advised on the importance of strict glycemic control to prevent disease progression.The patient is scheduled for panretinal photocoagulation (PRP) laser therapy to manage the proliferative diabetic retinopathy. The patient's diabetes management is optimized with insulin therapy adjustments.58FemaleCaucasian"
    },
    "8809": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus.The patient complains of blurred vision in the left eye without any signs of macular edema.Ophthalmologic examination revealed proliferative changes consistent with diabetic retinopathy without macular edema in the left eye.Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye. Verbatim EHR quote justifying the code: 'Proliferative diabetic retinopathy without macular edema in the left eye.'The patient's left eye fundus examination showed characteristic findings of proliferative diabetic retinopathy without macular edema.Initiated laser photocoagulation therapy for proliferative diabetic retinopathy.Patient responded well to treatment and was discharged with a follow-up scheduled in three months.55MaleCaucasian"
    },
    "8810": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and has been undergoing regular ophthalmologic screenings due to diabetic retinopathy.The patient reports no visual disturbances, pain, or changes in vision. Denies any symptoms of macular edema such as blurriness or distortion.Ophthalmologic examination revealed bilateral proliferative diabetic retinopathy without macular edema.Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral. Verbatim EHR quote justifying the code: 'Ophthalmologic examination revealed bilateral proliferative diabetic retinopathy without macular edema.'Patient's diabetes is well-controlled with current medication regimen. Advised on the importance of regular follow-ups with the ophthalmologist for diabetic retinopathy monitoring.Continuation of current diabetes management plan with close monitoring of blood glucose levels. Referral to the ophthalmologist for further evaluation and management of proliferative diabetic retinopathy.The patient is stable and discharged with instructions to follow up with the ophthalmologist in two weeks for further management of proliferative diabetic retinopathy.58FemaleCaucasian"
    },
    "8811": {
        "explanation_text": "Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and has been managing blood sugar levels with oral antidiabetic medications for the past five years.The patient reports no new visual disturbances, flashes of light, floaters, or vision loss.Recent fundoscopic examination reveals new vessel formation and fibrous proliferation in the retina without signs of macular edema.Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye. The patient presents with new vessel formation and fibrous proliferation in the retina without macular edema.Patient's blood pressure and blood glucose levels are within target ranges. Referral made to ophthalmology for further evaluation and management of proliferative diabetic retinopathy.Initiated panretinal photocoagulation therapy to manage proliferative changes in the retina. Continuation of current oral antidiabetic medication regimen.The patient responded well to treatment and was discharged with a follow-up appointment scheduled with the ophthalmology department in two weeks.58FemaleCaucasian"
    },
    "8812": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic cataract.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus for the past 10 years.The patient complains of blurry vision, glare sensitivity, and difficulty seeing at night.Ophthalmologic examination shows the presence of cataracts in both eyes.Diagnosis: Type 2 diabetes mellitus with diabetic cataract (E1136).The patient's fundoscopic exam revealed opacities in the lens consistent with diabetic cataract. No signs of retinopathy were observed.Treatment includes diabetic management with oral hypoglycemic agents, regular eye check-ups, and consideration for cataract surgery in the future.The patient was educated on the importance of glycemic control and regular ophthalmologic follow-ups for monitoring the progression of cataracts.65MaleCaucasian"
    },
    "8813": {
        "explanation_text": "Type 2 diabetes mellitus with other diabetic ophthalmic complication.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus under fair control with oral antidiabetic medication.The patient complains of blurred vision, eye pain, and sensitivity to light in both eyes.Ophthalmologic examination shows signs of diabetic ophthalmic complications without evidence of diabetic retinopathy, cataract, or neuropathy.Diagnosis: Diabetes mellitus type 2 with other diabetic ophthalmic complication. Verbatim EHR quote justifying the code: The ophthalmologic examination reveals diabetic ophthalmic complications without the characteristic signs of retinopathy, cataract, or neuropathy.The patient's diabetes management is fair, and ophthalmologic evaluation indicates the need for close monitoring of the diabetic ophthalmic complications. No signs of diabetic retinopathy, cataract, or neuropathy were noted during the examination.Treatment Plan: Continued management of Type 2 diabetes mellitus with lifestyle modifications and oral antidiabetic medication. Ophthalmology referral for specialized care of diabetic ophthalmic complications.The patient is stable and discharged with instructions for regular follow-up with both the endocrinology and ophthalmology departments for ongoing management and monitoring of diabetes and its associated ophthalmic complications.58 years oldFemaleCaucasian"
    },
    "8814": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic neuropathy, unspecified.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus, hypertension, and dyslipidemia.The patient presents with bilateral lower extremity numbness, tingling, and burning pain. The symptoms are worse at night and have been gradually progressing over the last few months.Nerve conduction studies revealed symmetric sensorimotor polyneuropathy consistent with diabetic neuropathy.Type 2 diabetes mellitus with diabetic neuropathy, unspecified (E1140)The patient's symptoms of bilateral lower extremity neuropathy are consistent with diabetic neuropathy. Nerve conduction studies confirmed the presence of polyneuropathy, supporting the diagnosis of diabetic neuropathy. No evidence of diabetic retinopathy, cataract, ophthalmic complications, peripheral angiopathy, autonomic neuropathy, foot ulcers, skin ulcers, or other neurological complications was found.Initiated treatment with pregabalin for neuropathic pain management. Recommended lifestyle modifications, including a diabetic diet and regular exercise. Follow-up in 3 months for symptom reassessment.56FemaleCaucasian"
    },
    "8815": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus for the past 10 years with well-controlled blood glucose levels. No history of diabetic retinopathy, cataract, or other ophthalmic complications.The patient complains of persistent gastrointestinal symptoms like bloating, nausea, and diarrhea. Additionally, reports symptoms of orthostatic hypotension, urinary incontinence, and erectile dysfunction.Nerve conduction studies revealed reduced heart rate variability, abnormal sweating patterns, and impaired gastrointestinal motility consistent with autonomic neuropathy.Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathyThe patient presents with classic symptoms of autonomic neuropathy, including gastrointestinal, cardiovascular, genitourinary, and sudomotor dysfunction. Physical examination findings support the diagnosis of autonomic neuropathy.Initiated treatment with a multidisciplinary approach including dietary modifications, physical therapy, and medications for symptomatic relief.The patient responded well to treatment and was discharged with a comprehensive plan for ongoing management of diabetic autonomic neuropathy.58MaleCaucasian"
    },
    "8816": {
        "explanation_text": "Type 2 diabetes mellitus with other diabetic neurological complication.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus with associated neurological complications.The patient presents with symptoms of numbness, tingling, and burning pain in the lower extremities.Nerve conduction studies revealed peripheral neuropathy consistent with diabetic neuropathy.Type 2 diabetes mellitus with other diabetic neurological complicationPatient reports difficulty walking due to neuropathic pain. Neurological examination shows decreased sensation in both feet. No signs of diabetic retinopathy or cataracts.Initiated treatment with gabapentin for neuropathic pain management. Recommended regular blood sugar monitoring and foot care.The patient responded well to treatment and was discharged with a plan for close follow-up to monitor neuropathy progression.58FemaleCaucasian"
    },
    "8817": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and hypertension.The patient complains of intermittent claudication in the lower limbs but denies any signs of infection or gangrene.ABI showed decreased values in the lower extremities consistent with peripheral arterial disease.Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene.Patient's lower limb pulses are diminished, and there are signs of peripheral vascular disease without any evidence of tissue necrosis.Started the patient on antiplatelet therapy and referred to vascular surgery for further management.The patient was stable throughout the hospital stay and was discharged with instructions for medication adherence and follow-up with the vascular surgeon.58MaleCaucasian"
    },
    "8818": {
        "explanation_text": "Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene.",
        "symptom_text": "The patient has a history of poorly controlled type 2 diabetes mellitus.The patient presents with pain, numbness, and black discoloration of toes on the right foot.Ankle-brachial index (ABI) shows severe peripheral arterial disease. Wound culture indicates the presence of multiple bacterial species.Diabetic peripheral angiopathy with gangrene of the right foot.The patient's gangrenous toes require urgent surgical intervention to prevent further tissue damage and systemic infection.The patient underwent a right partial foot amputation. Post-operative care includes broad-spectrum antibiotics, wound care, and diabetic management.The patient is stable post-amputation and will be followed up closely for wound healing and glycemic control.58MaleCaucasian"
    },
    "8819": {
        "explanation_text": "Type 2 diabetes mellitus with other circulatory complications.",
        "symptom_text": "The patient has a history of Type 2 diabetes mellitus and hypertension.The patient complains of intermittent claudication and numbness in the lower extremities.Ankle-brachial index (ABI) test revealed values suggestive of peripheral arterial disease.Type 2 diabetes mellitus with other circulatory complicationsPatient presents with signs of peripheral arterial disease, including intermittent claudication and abnormal ABI values. No evidence of diabetic retinopathy, neuropathy, or skin ulcers.Started on antiplatelet therapy and referred to vascular surgery for further management.Patient discharged in stable condition with scheduled follow-up for vascular intervention.58FemaleCaucasian"
    },
    "8820": {
        "explanation_text": "Type 2 diabetes mellitus with foot ulcer.",
        "symptom_text": "The patient has a longstanding history of Type 2 diabetes mellitus.The patient presents with a non-healing ulcer on the left foot, accompanied by pain, redness, and swelling. No signs of gangrene or peripheral angiopathy.Imaging studies reveal a deep ulcer on the left foot without signs of osteomyelitis.Type 2 diabetes mellitus with foot ulcer. Verbatim ICD-10-CM's verbatim_EHR_quote_justifying_the_code: 'Type 2 diabetes mellitus with other skin ulcer.'Patient reports increased pain over the ulcer site but denies any fever or chills. No signs of systemic infection.Wound care initiated with daily dressing changes, offloading the affected foot, and strict glucose monitoring.The patient responded well to treatment, with gradual healing of the foot ulcer. Discharged with instructions for wound care and diabetic management.58FemaleCaucasian"
    },
    "8821": {
        "explanation_text": "Type 2 diabetes mellitus with hypoglycemia without coma.",
        "symptom_text": "The patient has a known medical history of Type 2 diabetes mellitus.The patient presents with symptoms of sweating, dizziness, and confusion.Laboratory tests show low blood glucose levels of 55 mg/dL.Type 2 diabetes mellitus with hypoglycemia without coma.Patient's blood glucose levels were monitored, and hypoglycemia was managed effectively.The patient was treated with intravenous dextrose and advised on glucose monitoring.The patient's condition improved with treatment, and education was provided on hypoglycemia management.58FemaleCaucasian"
    },
    "8822": {
        "explanation_text": "Other specified diabetes mellitus with diabetic chronic kidney disease.",
        "symptom_text": "The patient has a long-standing history of type 2 diabetes mellitus with poor glycemic control. The patient has a history of hypertension and dyslipidemia. There is a documented history of diabetic retinopathy. The patient has a history of smoking.The patient presents with polyuria, polydipsia, and fatigue. There are no symptoms of neuropathic arthropathy, foot ulcers, or other skin complications.Recent lab results show elevated serum creatinine and proteinuria, indicating kidney dysfunction. HbA1c levels are elevated, reflecting poor glucose control over the past few months.Other specified diabetes mellitus with diabetic chronic kidney disease.The patient's kidney function is significantly compromised due to diabetic nephropathy. Strict glucose control and blood pressure management are crucial to slow the progression of kidney disease. Referral to a nephrologist is recommended for further evaluation and management.The patient is started on an ACE inhibitor for renal protection. Insulin therapy is initiated to improve glycemic control. Lifestyle modifications including dietary changes and increased physical activity are advised.The patient is stable and is discharged with close follow-up instructions. Education on diabetes management and the importance of adherence to medications is provided.58 years oldMaleCaucasian"
    },
    "8823": {
        "explanation_text": "Other specified diabetes mellitus with hypoglycemia without coma.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus and has been compliant with their diabetes management.The patient presented with episodes of hypoglycemia, including sweating, palpitations, and confusion, without any signs of coma.Blood glucose levels were measured below 70 mg/dL during the hypoglycemic episodes.Other specified diabetes mellitus with hypoglycemia without coma. The patient's hypoglycemia episodes were documented without any signs of coma, aligning with the criteria for code E13.649.The patient responded well to glucose administration during the hypoglycemic episodes and did not require hospitalization.The patient was advised on adjustments to their insulin regimen to prevent further hypoglycemic episodes.The patient was discharged in stable condition with instructions for glucose monitoring and follow-up with their primary care physician.55FemaleCaucasian"
    },
    "8824": {
        "explanation_text": "Drug-induced hypoglycemia without coma.",
        "symptom_text": "The patient has a history of hypertension and dyslipidemia managed with amlodipine and atorvastatin. No history of diabetes mellitus or other endocrine disorders.The patient presented with diaphoresis, palpitations, and confusion. No signs of hyperglycemia or diabetic ketoacidosis.Blood glucose level was 50 mg/dL. HbA1c within normal limits. No ketones in urine. Electrolyte panel unremarkable.Drug-induced hypoglycemia without coma. The patient developed hypoglycemia due to the use of a sulfonylurea medication.The patient's hypoglycemia is attributed to the sulfonylurea medication. No evidence of diabetic complications or hyperglycemia. Coma ruled out.The patient was treated with IV dextrose and monitored closely. Discontinued the sulfonylurea medication. Educated the patient on the signs and symptoms of hypoglycemia.The patient's symptoms resolved with treatment, and blood glucose levels stabilized. Discharged with instructions to follow up with the primary care physician for medication adjustment.58FemaleCaucasian"
    },
    "8825": {
        "explanation_text": "Increased secretion of gastrin.",
        "symptom_text": "The patient has a history of chronic gastritis and peptic ulcers.The patient presents with recurrent abdominal pain, nausea, vomiting, and unintentional weight loss.Laboratory tests show markedly elevated serum gastrin levels.Increased secretion of gastrin (ICD-10-CM code E164)The patient reports a long-standing history of gastritis symptoms, and diagnostic tests confirm significantly elevated gastrin levels, supporting the diagnosis of Increased secretion of gastrin.The patient is started on proton pump inhibitors to manage the increased gastrin levels and alleviate symptoms.The patient responded well to treatment and is advised to follow up with a gastroenterologist for further management of Increased secretion of gastrin.55FemaleCaucasian"
    },
    "8826": {
        "explanation_text": "Primary hyperparathyroidism.",
        "symptom_text": "The patient has a history of recurrent kidney stones and complains of bone pain, fatigue, and frequent urination.The patient presents with bone pain, fatigue, recurrent kidney stones, and increased urination.Laboratory tests show elevated serum calcium levels, low phosphate levels, and increased parathyroid hormone levels.Primary hyperparathyroidism (ICD-10-CM code E210): Primary hyperparathyroidism is characterized by the overproduction of parathyroid hormone from one or more parathyroid glands, leading to hypercalcemia, low phosphate levels, and bone resorption. The verbatim_EHR_quote_justifying_the_code: 'Laboratory tests confirmed elevated serum calcium levels, low phosphate levels, and increased parathyroid hormone levels, consistent with a diagnosis of Primary hyperparathyroidism.'The endocrinologist noted the classic constellation of symptoms along with the biochemical profile indicative of Primary hyperparathyroidism. Imaging studies revealed a single parathyroid adenoma.The patient was started on hydration therapy, advised to increase physical activity, and scheduled for a parathyroidectomy.The patient responded well to treatment, with normalization of calcium and parathyroid hormone levels post-surgery. Discharged in stable condition with follow-up scheduled in two weeks.58FemaleCaucasian"
    },
    "8827": {
        "explanation_text": "Secondary hyperparathyroidism, not elsewhere classified.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 due to hypertension for the past 5 years.Reports bone pain, especially in the hips and lower back. No history of recurrent kidney stones or pancreatitis.Laboratory findings show elevated serum PTH level of 110 pg/mL (normal range: 15-65 pg/mL), hypocalcemia with serum calcium level of 8.2 mg/dL (normal range: 8.5-10.5 mg/dL), and hyperphosphatemia with serum phosphorus level of 5.0 mg/dL (normal range: 2.5-4.5 mg/dL). DEXA scan reveals osteopenia in the lumbar spine.Secondary hyperparathyroidism, not elsewhere classified. The diagnosis is supported by the history of chronic kidney disease stage 3, elevated serum PTH levels, abnormal calcium and phosphorus levels, and osteopenia on DEXA scan.Patient shows classic biochemical and bone findings consistent with secondary hyperparathyroidism due to chronic kidney disease. Initiate treatment to manage secondary hyperparathyroidism while optimizing chronic kidney disease management.Treatment includes dietary phosphate restriction, active vitamin D therapy, and phosphate binders to control serum phosphorus levels. Follow-up with endocrinology in 2 weeks.Patient discharged in stable condition with close outpatient follow-up for monitoring and management of secondary hyperparathyroidism and chronic kidney disease.58FemaleCaucasian"
    },
    "8828": {
        "explanation_text": "Other hyperparathyroidism.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3.The patient presented with fatigue, muscle weakness, and bone pain.Laboratory tests showed elevated serum calcium levels and high parathyroid hormone (PTH) levels.Other hyperparathyroidism (ICD-10-CM code E212): 'Other hyperparathyroidism' is a condition characterized by overactivity of the parathyroid glands, leading to increased levels of parathyroid hormone (PTH) and hypercalcemia. In this case, the patient presented with elevated serum calcium levels and high PTH levels, consistent with the diagnosis of Other hyperparathyroidism.The patient's symptoms of fatigue, muscle weakness, and bone pain, along with the laboratory findings of elevated serum calcium and high PTH levels, support the diagnosis of Other hyperparathyroidism. There is no evidence of drug-induced hypoglycemia, gastrin secretion disorders, or other pituitary disorders.The patient was started on calcimimetics to help lower the elevated calcium levels and advised on dietary changes to manage hyperparathyroidism.The patient responded well to treatment and was discharged with instructions for follow-up monitoring of calcium and PTH levels.58FemaleCaucasian"
    },
    "8829": {
        "explanation_text": "Acromegaly and pituitary gigantism.",
        "symptom_text": "The patient has a medical history of chronic headaches, vision problems, and recent rapid growth of hands and feet over the past two years.The patient presents with enlarged hands and feet, coarsened facial features, headaches, and visual field disturbances.MRI revealed a pituitary adenoma, and laboratory tests indicated elevated serum growth hormone levels.Acromegaly and pituitary gigantism. The patient presents with characteristic symptoms of acral enlargement, coarsened facial features, headaches, visual disturbances, and elevated growth hormone levels, consistent with a pituitary adenoma on imaging.The patient's physical examination is significant for acromegalic features with enlarged extremities and facial changes. The MRI findings confirm the presence of a pituitary adenoma, correlating with the clinical suspicion of acromegaly.The patient is scheduled for transsphenoidal surgery to remove the pituitary adenoma. Postoperatively, the patient will require hormone replacement therapy and close monitoring of growth hormone levels.The patient underwent successful pituitary adenoma resection and is recovering well postoperatively. Discharge instructions include follow-up with endocrinology for hormone replacement therapy and monitoring.45FemaleCaucasian"
    },
    "8830": {
        "explanation_text": "Hyperprolactinemia.",
        "symptom_text": "The patient has a history of irregular menstrual cycles and infertility.The patient presents with galactorrhea and complains of headaches.Prolactin levels are markedly elevated at 85 ng/mL (normal range: 2-18 ng/mL). MRI of the pituitary gland shows a 6 mm microadenoma.Hyperprolactinemia (E221) - Elevated prolactin levels causing galactorrhea and infertility. Prolactin levels: 85 ng/mL (normal range: 2-18 ng/mL).The patient's symptoms and diagnostic tests are consistent with hyperprolactinemia. Initiating treatment with cabergoline 0.5 mg weekly.Cabergoline 0.5 mg weekly to reduce prolactin levels and shrink the pituitary adenoma.Patient responded well to cabergoline therapy with resolution of galactorrhea. Scheduled for follow-up prolactin level check in 6 weeks.32FemaleCaucasian"
    },
    "8831": {
        "explanation_text": "Hypopituitarism.",
        "symptom_text": "The patient has a history of fatigue, weight loss, cold intolerance, and decreased libido.The patient presents with fatigue, weight loss, cold intolerance, decreased libido, and hypotension.Laboratory tests revealed low levels of thyroid-stimulating hormone, adrenocorticotropic hormone, and growth hormone.Hypopituitarism (E230): Decreased secretion of one or more pituitary hormones.The patient's symptoms and laboratory findings are consistent with hypopituitarism, indicating a deficiency in multiple pituitary hormones.The patient was started on hormone replacement therapy to address the deficiencies identified.The patient responded well to treatment and was discharged with instructions to follow up with an endocrinologist for further management.45FemaleCaucasian"
    },
    "8832": {
        "explanation_text": "Diabetes insipidus.",
        "symptom_text": "The patient has a history of head trauma following a car accident five years ago. No significant endocrine disorders reported previously.The patient presents with excessive thirst, passing large volumes of urine, and feeling fatigued.Laboratory tests reveal low urine osmolality and high serum osmolality. Serum sodium levels are elevated.Diabetes insipidus (E232): Diabetes insipidus is a condition characterized by the excretion of large amounts of dilute urine, excessive thirst, and polydipsia. It results from inadequate output of antidiuretic hormone (ADH) or the kidney's inability to respond to ADH. The key findings supporting this diagnosis in this patient include polyuria, polydipsia, and laboratory results showing low urine osmolality and high serum osmolality.The patient reports a significant increase in urine output over the past few weeks, drinking excessive amounts of water to quench the thirst. Physical examination reveals no signs of edema or significant weight changes.The patient was started on desmopressin acetate to replace the antidiuretic hormone and instructed to follow up for monitoring of symptoms and electrolyte levels.The patient responded well to desmopressin acetate therapy with a reduction in urine output and improvement in symptoms. Discharged home with instructions for follow-up visits.42MaleCaucasian"
    },
    "8833": {
        "explanation_text": "Drug-induced Cushing's syndrome.",
        "symptom_text": "The patient has a history of rheumatoid arthritis and has been on long-term prednisone therapy for the past two years.The patient presents with central obesity, moon face, muscle weakness, and easy bruising.Laboratory tests revealed elevated cortisol levels and lack of ACTH suppression on the dexamethasone suppression test.Drug-induced Cushing's syndrome: The patient presents with typical symptoms of central obesity, moon face, muscle weakness, and easy bruising along with elevated cortisol levels and lack of ACTH suppression on the dexamethasone suppression test, consistent with drug-induced Cushing's syndrome.The patient's symptoms and laboratory findings are highly suggestive of Cushing's syndrome induced by long-term corticosteroid therapy. Discontinuation of prednisone and gradual tapering under endocrinology consultation is advised.The patient will be started on a tapering schedule of prednisone under close monitoring. Referral to an endocrinologist for further management and monitoring of adrenal function is recommended.The patient's condition improved with the tapering of prednisone. Discharged with a plan for outpatient endocrinology follow-up.54FemaleCaucasian"
    },
    "8834": {
        "explanation_text": "Cushing's syndrome, unspecified.",
        "symptom_text": "The patient has a history of uncontrolled hypertension, weight gain, easy bruising, and muscle weakness.The patient presents with central obesity, moon face, buffalo hump, and thinning of the skin.Laboratory tests show elevated cortisol levels, lack of diurnal variation, and lack of suppression on low-dose dexamethasone suppression test.Cushing's syndrome, unspecified. Verbatim EHR quote justifying the code: 'The patient presents with central obesity, moon face, buffalo hump, thinning of the skin, elevated cortisol levels, lack of diurnal variation, and lack of suppression on low-dose dexamethasone suppression test.'The endocrinologist confirmed the diagnosis of Cushing's syndrome based on the clinical presentation and laboratory findings.Treatment with metyrapone initiated to control cortisol levels. Referral to an endocrine surgeon for further management.The patient's condition improved with treatment, and arrangements for outpatient follow-up with the endocrinology department were made.45FemaleCaucasian"
    },
    "8835": {
        "explanation_text": "Other primary hyperaldosteronism.",
        "symptom_text": "The patient has a history of hypertension for the past 5 years, which has been difficult to control despite multiple antihypertensive medications.The patient presents with uncontrolled hypertension, muscle weakness, and occasional muscle cramps.Lab results show elevated aldosterone levels and suppressed renin levels. CT scan of the abdomen reveals a 2 cm mass on the left adrenal gland.Other primary hyperaldosteronism (E2609)The patient's symptoms, along with lab results showing elevated aldosterone levels, suppressed renin levels, and imaging findings of an adrenal mass, are consistent with a diagnosis of Other primary hyperaldosteronism.Initiated treatment with spironolactone to manage hyperaldosteronism and referred the patient to an endocrinologist for further management.The patient's blood pressure is now under better control with the new medication regimen. Discharged with a follow-up appointment in two weeks.58FemaleCaucasian"
    },
    "8836": {
        "explanation_text": "Hyperaldosteronism, unspecified.",
        "symptom_text": "The patient has a history of hypertension and occasional muscle weakness but no prior endocrine disorders.The patient presents with uncontrolled hypertension, muscle weakness, and occasional headaches.Laboratory tests show low serum potassium levels and metabolic alkalosis. Aldosterone levels are elevated, confirming hyperaldosteronism.Primary Diagnosis: Hyperaldosteronism, unspecified. Verbatim EHR quote justifying the code: 'Patient presents with uncontrolled hypertension, hypokalemia, and metabolic alkalosis along with elevated aldosterone levels.'The patient's symptoms and diagnostic tests are consistent with primary hyperaldosteronism. No signs of pituitary or adrenal insufficiency are noted.Treatment includes spironolactone to block the effects of aldosterone and manage blood pressure.The patient responded well to treatment and was discharged with a follow-up appointment in two weeks.56FemaleCaucasian"
    },
    "8837": {
        "explanation_text": "Primary adrenocortical insufficiency.",
        "symptom_text": "The patient has a history of autoimmune disorders, including Hashimoto's thyroiditis and type 1 diabetes mellitus.The patient presented with fatigue, weight loss, hypotension, hyperpigmentation, and salt cravings.Laboratory tests revealed low cortisol levels, high ACTH levels, hyponatremia, and hyperkalemia.Primary adrenocortical insufficiency (ICD-10-CM code E271): The patient presents with fatigue, weight loss, hypotension, hyperpigmentation, and salt cravings, along with laboratory findings of low cortisol levels, high ACTH levels, hyponatremia, and hyperkalemia.The patient's symptoms and diagnostic tests are consistent with primary adrenocortical insufficiency, likely due to autoimmune destruction of the adrenal cortex.Treatment includes glucocorticoid and mineralocorticoid replacement therapy to manage adrenal insufficiency.The patient responded well to treatment and was discharged with instructions for medication management and follow-up with endocrinology.45FemaleCaucasian"
    },
    "8838": {
        "explanation_text": "Other specified disorders of adrenal gland.",
        "symptom_text": "The patient has a history of hypertension, unexplained weight gain, and fatigue.The patient presents with symptoms of unexplained weight gain, easy bruising, and muscle weakness.Laboratory tests revealed elevated levels of cortisol and aldosterone, along with a normal ACTH stimulation test.Other specified disorders of adrenal gland (E278): The patient presents with symptoms of unexplained weight gain, easy bruising, and muscle weakness. Laboratory tests revealed elevated levels of cortisol and aldosterone, along with a normal ACTH stimulation test.The patient's physical examination showed central obesity, purple striae on the abdomen, and proximal muscle weakness. These findings are indicative of an adrenal gland disorder.The patient was started on spironolactone to manage the aldosterone excess and instructed to follow a low-sodium diet.The patient responded well to treatment and was discharged with instructions for follow-up monitoring of cortisol and aldosterone levels.45FemaleCaucasian"
    },
    "8839": {
        "explanation_text": "Disorder of adrenal gland, unspecified.",
        "symptom_text": "The patient has a history of hypertension and fatigue.The patient presents with weakness, weight loss, and dizziness.Laboratory tests show electrolyte imbalances and elevated plasma renin activity.Disorder of adrenal gland, unspecified: The patient presents with weakness, weight loss, and dizziness, along with laboratory findings of electrolyte imbalances and elevated plasma renin activity, suggestive of an adrenal gland disorder. These findings support the diagnosis of Disorder of adrenal gland, unspecified (E279).The patient's symptoms and lab results are consistent with an adrenal gland disorder. No specific etiology or subtype is identified at this time.The patient is started on hydrocortisone replacement therapy and advised on dietary modifications.The patient responded well to treatment and is stable for discharge. Follow-up with endocrinology is recommended for further management.45FemaleCaucasian"
    },
    "8840": {
        "explanation_text": "Polycystic ovarian syndrome.",
        "symptom_text": "The patient has a history of irregular menstrual cycles and difficulty conceiving for the past two years.The patient presents with irregular menstrual periods, hirsutism, and acne.Laboratory tests revealed elevated levels of androgens. Transvaginal ultrasound showed polycystic ovaries.Polycystic ovarian syndrome (E282): The patient presents with irregular menstrual cycles, hirsutism, acne, elevated androgens, and polycystic ovaries on imaging.The patient reports concerns regarding infertility and is seeking management options.Treatment includes oral contraceptive pills to regulate menstrual cycles and manage androgen levels. Lifestyle modifications and weight management strategies are advised.The patient was discharged with a follow-up appointment in six weeks to assess treatment response and adjust management as needed.28FemaleCaucasian"
    },
    "8841": {
        "explanation_text": "Testicular hypofunction.",
        "symptom_text": "The patient, a 35-year-old male, has a history of testicular trauma during childhood but no other significant medical history.The patient complains of decreased libido, erectile dysfunction, fatigue, and difficulty conceiving a child with his partner.Laboratory tests revealed low serum testosterone levels of 250 ng/dL (normal range 300-1000 ng/dL), elevated FSH levels of 25 mIU/mL (normal range 1.5-12.4 mIU/mL), and elevated LH levels of 20 mIU/mL (normal range 1.7-8.6 mIU/mL).Testicular hypofunction (E291): The decreased function of the testes leading to insufficient testosterone production.The patient's symptoms and laboratory results are consistent with testicular hypofunction. No signs of adrenal insufficiency or ovarian disorders are present.The patient has been started on testosterone replacement therapy and referred to a reproductive endocrinologist for further evaluation and management.The patient responded well to testosterone replacement therapy during the hospital stay. Discharge instructions include follow-up with the endocrinologist in two weeks for treatment monitoring.35MaleCaucasian"
    },
    "8842": {
        "explanation_text": "Mild protein-calorie malnutrition.",
        "symptom_text": "The patient has a history of poor appetite and unintentional weight loss over the past few months.The patient reports feeling fatigued, experiencing mild muscle weakness, and noticing a slight decrease in weight.Laboratory tests revealed mild hypoalbuminemia with normal electrolyte levels.Mild protein-calorie malnutritionPatient presents with mild protein-calorie malnutrition, exhibiting mild symptoms and mild hypoalbuminemia without severe manifestations.Initiated a high-protein and high-calorie diet plan along with nutritional supplements. Follow-up scheduled in two weeks for reassessment.The patient responded well to the dietary changes and supplements. Discharged with dietary recommendations and follow-up instructions.45FemaleCaucasian"
    },
    "8843": {
        "explanation_text": "Unspecified protein-calorie malnutrition.",
        "symptom_text": "The patient has a history of poor appetite and unintentional weight loss over the past few months.The patient presents with generalized weakness, fatigue, and muscle wasting.Laboratory tests indicate low serum albumin and total protein levels.Unspecified protein-calorie malnutrition (ICD-10-CM code E46) - The patient presents with poor appetite, weight loss, generalized weakness, fatigue, and low serum albumin and total protein levels, indicative of protein-calorie malnutrition.The patient's malnutrition is likely due to inadequate dietary intake or malabsorption. Nutritional counseling and high-protein diet advised.The patient was started on oral nutritional supplements and referred to a dietitian for further management.The patient responded well to treatment, showed improvement in symptoms, and was discharged with dietary recommendations and follow-up appointments scheduled.58FemaleCaucasian"
    },
    "8844": {
        "explanation_text": "Vitamin A deficiency, unspecified.",
        "symptom_text": "The patient has a history of a diet low in fruits, vegetables, and dairy products, which are common sources of Vitamin A.The patient presents with night blindness, dry skin, dry eyes, and frequent infections suggestive of impaired immune function.Laboratory tests revealed low serum retinol levels of 15 \u00b5g/dL (normal range: 30-80 \u00b5g/dL). Dark adaptation tests showed delayed recovery time, indicating Vitamin A deficiency.Vitamin A deficiency, unspecified. Verbatim EHR quote justifying the code: 'Patient presents with symptoms of night blindness, dry skin, and low serum retinol levels, consistent with Vitamin A deficiency.'Patient reports a gradual onset of night blindness over the past few months. Physical examination shows dry, scaly skin and conjunctival xerosis. The patient's immune function appears compromised.Initiated treatment with Vitamin A supplements at 10,000 IU/day orally. Advised to increase intake of Vitamin A-rich foods.Patient responded well to treatment and symptoms improved. Discharged with instructions to continue Vitamin A supplements and follow-up with a dietitian for nutritional counseling.45FemaleCaucasian"
    },
    "8845": {
        "explanation_text": "Wernicke's encephalopathy.",
        "symptom_text": "The patient has a history of chronic alcoholism and poor nutritional intake.The patient presents with confusion, abnormal eye movements, and difficulty walking.Thiamine levels were significantly low, and an MRI showed characteristic changes in the thalamus and mammillary bodies.Wernicke's encephalopathy. Verbatim EHR quote justifying the code: 'Patient presents with confusion, abnormal eye movements, and difficulty walking, along with low thiamine levels and characteristic MRI findings in the thalamus and mammillary bodies.'The patient's symptoms and diagnostic results are consistent with Wernicke's encephalopathy. Immediate thiamine replacement therapy has been initiated.Thiamine replacement therapy intravenously at high doses.The patient showed improvement with thiamine therapy and is advised to follow up with a nutritionist for dietary optimization post-discharge.56MaleCaucasian"
    },
    "8846": {
        "explanation_text": "Thiamine deficiency, unspecified.",
        "symptom_text": "The patient has a history of poor dietary intake due to financial constraints and a recent bariatric surgery, which can lead to thiamine deficiency.The patient presents with weakness, fatigue, irritability, and peripheral neuropathy, which are common symptoms of thiamine deficiency.Laboratory tests reveal decreased thiamine levels in the blood, confirming thiamine deficiency.Thiamine deficiency, unspecified. Verbatim EHR quote justifying the code: 'Laboratory tests confirm decreased thiamine levels in the blood, consistent with thiamine deficiency.'The patient's symptoms and lab results align with a diagnosis of thiamine deficiency. There are no signs of altered mental status or ophthalmoplegia to suggest Wernicke's encephalopathy.The patient was started on thiamine supplementation therapy to correct the deficiency.The patient responded well to thiamine supplementation and was discharged with instructions to maintain a balanced diet rich in thiamine sources.45FemaleCaucasian"
    },
    "8847": {
        "explanation_text": "Deficiency of other specified B group vitamins.",
        "symptom_text": "The patient has a history of a vegetarian diet for the past five years.The patient presents with fatigue, pale skin, and tingling sensations in the hands and feet.Lab results show decreased levels of vitamin B12 and folate.Deficiency of other specified B group vitamins (ICD-10-CM code E538): The patient presents with fatigue, pale skin, and tingling sensations in the hands and feet. Lab results indicate decreased levels of vitamin B12 and folate, consistent with a deficiency of other specified B group vitamins.The patient's symptoms and lab results are indicative of a deficiency of other specified B group vitamins, likely due to the prolonged vegetarian diet.The patient was started on vitamin B12 and folate supplements and advised to incorporate more vitamin-rich foods into their diet.The patient's symptoms improved with treatment, and they were discharged with a prescription for continued supplementation and dietary changes.42FemaleCaucasian"
    },
    "8848": {
        "explanation_text": "Magnesium deficiency.",
        "symptom_text": "The patient has a history of poor dietary intake due to financial constraints.The patient presents with muscle weakness, fatigue, and palpitations.Lab results indicate low serum magnesium levels of 1.5 mg/dL (normal range: 1.7-2.2 mg/dL).Magnesium deficiency (ICD-10-CM code E612): Verbatim_EHR_quote_justifying_the_codePatient shows signs of hypomagnesemia with associated symptoms of muscle weakness and cardiac arrhythmias.The patient was started on oral magnesium supplements and advised on dietary modifications rich in magnesium.The patient's symptoms improved with treatment, and serum magnesium levels normalized. Discharged with dietary recommendations and follow-up scheduled in two weeks.45FemaleCaucasian"
    },
    "8849": {
        "explanation_text": "Other specified nutritional deficiencies.",
        "symptom_text": "The patient has a history of a restrictive diet due to food allergies, leading to inadequate intake of specific nutrients.The patient presents with fatigue, muscle weakness, and hair loss.Laboratory tests show low serum levels of the specific nutrient in question.Other specified nutritional deficiencies (ICD-10-CM code E638): The patient presents with fatigue, muscle weakness, and hair loss, along with low serum levels of the specific nutrient, consistent with a diagnosis of Other specified nutritional deficiencies.The patient reports a restricted diet due to food allergies, which likely contributed to the nutritional deficiency. The symptoms and lab results support the diagnosis of Other specified nutritional deficiencies.The patient was started on oral supplements of the deficient nutrient and advised on dietary modifications.The patient's symptoms improved with supplementation, and dietary changes were advised upon discharge.42FemaleCaucasian"
    },
    "8850": {
        "explanation_text": "Nutritional deficiency, unspecified.",
        "symptom_text": "The patient has a history of poor dietary habits with limited intake of fresh fruits, vegetables, and lean proteins.The patient presents with complaints of generalized fatigue, muscle weakness, and difficulty concentrating.Laboratory tests revealed decreased levels of multiple essential vitamins and minerals without specificity to any particular nutrient deficiency.Nutritional deficiency, unspecified. Verbatim_EHR_quote_justifying_the_code: The patient presents with generalized fatigue, muscle weakness, and laboratory results showing decreased levels of multiple essential vitamins and minerals without specificity to any particular nutrient deficiency.Patient appears pale and fatigued during the examination. No signs of specific nutrient deficiencies such as dermatological manifestations or neurological symptoms.The patient was prescribed a daily multivitamin supplement and referred to a nutritionist for dietary counseling.The patient responded well to the treatment and was discharged with instructions to follow up with the nutritionist regularly.45FemaleCaucasian"
    },
    "8851": {
        "explanation_text": "Localized adiposity.",
        "symptom_text": "The patient has a history of localized fat accumulation in the abdominal region.The patient presents with concerns about excess fat specifically in the abdominal area, without any systemic symptoms or signs of nutritional deficiencies.Physical examination reveals a disproportionate accumulation of fat in the abdominal region with a normal BMI and no signs of vitamin deficiencies.Localized adiposity (E65): The patient presents with localized fat accumulation in the abdominal region without evidence of generalized obesity or nutritional deficiencies. Verbatim EHR quote justifying the code: 'The patient exhibits localized adiposity with excess fat deposition in the abdominal area, disproportionate to the rest of the body.'Upon examination, the patient's fat distribution pattern aligns with localized adiposity, and no signs of systemic nutritional deficiencies or generalized obesity are noted.Recommendations for dietary modifications and targeted exercises to address the localized fat accumulation in the abdominal region.The patient was discharged with instructions for lifestyle changes to manage localized adiposity effectively.42FemaleCaucasian"
    },
    "8852": {
        "explanation_text": "Morbid (severe) obesity due to excess calories.",
        "symptom_text": "The patient has a history of gradual weight gain over the past five years, with a significant increase in body mass index (BMI) to 42.5 kg/m\u00b2.The patient reports fatigue, shortness of breath on exertion, and difficulty with mobility.Laboratory tests reveal elevated fasting glucose levels, dyslipidemia, and no evidence of vitamin deficiencies.Morbid (severe) obesity due to excess calories. Verbatim EHR quote justifying the code: 'Patient presents with a BMI of 42.5 kg/m\u00b2, fatigue, shortness of breath, and no evidence of vitamin deficiencies, consistent with morbid obesity due to excess calories.'The physician notes the challenges the patient faces in performing daily activities due to excessive weight. The patient's obesity is impacting their quality of life and overall health.The patient is advised on a calorie-restricted diet, increased physical activity, and referral to a nutritionist for dietary counseling. Follow-up appointments are scheduled to monitor progress.42FemaleCaucasian"
    },
    "8853": {
        "explanation_text": "Other obesity due to excess calories.",
        "symptom_text": "The patient has a history of gradual weight gain over the past few years, attributed to a high-calorie diet and lack of regular physical activity.The patient reports fatigue, joint pain, and shortness of breath on exertion.Laboratory tests show elevated cholesterol levels and mild insulin resistance.Other obesity due to excess calories. Verbatim_EHR_quote_justifying_the_code: 'The patient presents with a history of gradual weight gain due to excess calorie intake and lacks the criteria for severe obesity or specific nutrient deficiencies.'The physician notes the importance of lifestyle modifications, including dietary changes and increased physical activity, to manage the patient's obesity.The patient is advised to follow a balanced low-calorie diet, increase physical activity, and attend regular follow-up appointments for monitoring.The patient is discharged with recommendations for a weight management program and a follow-up appointment in one month.42FemaleCaucasian"
    },
    "8854": {
        "explanation_text": "Morbid (severe) obesity with alveolar hypoventilation.",
        "symptom_text": "The patient has a history of obesity and has been struggling with weight management for several years. No history of vitamin deficiencies, amino acid transport disorders, or other metabolic conditions.The patient presents with severe obesity, with a BMI of 45, and complains of excessive daytime sleepiness, morning headaches, and shortness of breath. The patient also reports episodes of gasping for air during sleep.Polysomnography results indicate hypoventilation during sleep, with an elevated arterial carbon dioxide level. Pulmonary function tests show decreased lung volumes and impaired gas exchange.Morbid (severe) obesity with alveolar hypoventilation. Verbatim EHR quote justifying the code: 'Patient presents with severe obesity (BMI 45) and symptoms of alveolar hypoventilation, including excessive daytime sleepiness, morning headaches, and gasping for air during sleep. Diagnostic tests confirm hypoventilation during sleep with elevated arterial carbon dioxide levels.'The patient's physical examination reveals obesity-related findings such as acanthosis nigricans and large neck circumference. No signs of vitamin deficiencies, amino acid disorders, or other metabolic issues observed.The patient was started on continuous positive airway pressure (CPAP) therapy for alveolar hypoventilation and referred to a multidisciplinary weight management program for severe obesity.The patient responded well to CPAP therapy, with improvement in symptoms of hypoventilation. Discharged with a follow-up plan for weight management and sleep studies to monitor progress.42FemaleCaucasian"
    },
    "8855": {
        "explanation_text": "Overweight.",
        "symptom_text": "The patient has a history of gradual weight gain over the past few years despite no significant changes in diet or physical activity levels.The patient reports increased body weight, particularly around the abdomen and hips, leading to concerns about obesity-related health risks.Laboratory tests indicate elevated BMI (Body Mass Index) and waist circumference measurements, consistent with the diagnosis of Overweight.Overweight (E663): Overweight is defined as an abnormal or excessive fat accumulation that presents a risk to health. It is diagnosed when the BMI is equal to or greater than 25 but less than 30. The patient's elevated BMI and waist circumference measurements confirm the diagnosis of Overweight.The patient shows no signs of nutritional deficiencies or genetic disorders related to metabolism. The focus of the treatment plan is to address the excess weight through lifestyle modifications.The patient is advised to follow a balanced diet, increase physical activity, and attend regular follow-up appointments to monitor weight progress.42FemaleCaucasian"
    },
    "8856": {
        "explanation_text": "Obesity, unspecified.",
        "symptom_text": "The patient has a history of gradual weight gain over the past few years despite attempts at dieting and exercise.The patient reports fatigue, shortness of breath on exertion, and joint pain exacerbated by weight-bearing activities.Laboratory tests show elevated BMI of 35, normal iron levels, and no abnormalities in magnesium or other nutritional markers.Obesity, unspecified. Verbatim EHR quote justifying the code: 'Patient presents with a BMI of 35, fatigue, shortness of breath, and joint pain exacerbated by weight-bearing activities.'The physician notes the patient's BMI places them in the obese category, and the symptoms reported are consistent with the diagnosis of obesity.Treatment includes dietary counseling, exercise recommendations, and a referral to a nutritionist for weight management.The patient was discharged with a follow-up appointment scheduled in two weeks to monitor progress in weight management.42FemaleCaucasian"
    },
    "8857": {
        "explanation_text": "Albinism, unspecified.",
        "symptom_text": "The patient has a known history of albinism since childhood, with regular follow-ups at the dermatology clinic.The patient presents with classic symptoms of albinism, including pale skin, light hair, and light-colored irises. There are no symptoms suggestive of other conditions.Genetic testing confirmed the presence of mutations associated with albinism.Albinism, unspecified. The patient exhibits the typical signs of albinism, including hypopigmentation of the skin, hair, and eyes.The patient reports no new symptoms related to albinism. Routine follow-up recommended in six months.No specific treatment needed for albinism. Sun protection advised to prevent sunburn and skin damage.N/A25FemaleCaucasian"
    },
    "8858": {
        "explanation_text": "Ruvalcaba-Myhre-Smith syndrome.",
        "symptom_text": "The patient has a history of developmental delays and intellectual disabilities since childhood. There is no family history of similar conditions.The patient presents with dysmorphic facial features including a broad forehead, hypertelorism, downslanting palpebral fissures, and a broad nasal bridge. Additionally, the patient has skeletal abnormalities such as short stature, pectus deformity, and joint hypermobility.Genetic testing revealed a mutation in the NSDHL gene, confirming the diagnosis of Ruvalcaba-Myhre-Smith syndrome.Ruvalcaba-Myhre-Smith syndrome is characterized by intellectual disability, developmental delays, dysmorphic facial features, skeletal abnormalities, and mutations in the NSDHL gene.The patient's physical examination and genetic test results are consistent with Ruvalcaba-Myhre-Smith syndrome. The patient will benefit from early intervention services and multidisciplinary care to address their developmental and medical needs.The patient will be referred to a developmental pediatrician, genetic counselor, and physical therapist for ongoing management and support.The patient will be discharged with recommendations for long-term follow-up to monitor developmental progress and address any emerging medical issues.8 years oldMaleCaucasian"
    },
    "8859": {
        "explanation_text": "Homocystinuria.",
        "symptom_text": "The patient has a known history of homocystinuria, an autosomal recessive disorder affecting the metabolism of the amino acid methionine.The patient presents with symptoms including ectopia lentis, intellectual disability, skeletal abnormalities, and a history of thromboembolic events.Laboratory tests revealed significantly elevated levels of homocysteine in both blood and urine. Molecular genetic testing confirmed compound heterozygous mutations in the CBS gene.Homocystinuria (ICD-10-CM code E7211): Homocystinuria due to cystathionine beta-synthase deficiencyThe patient's presentation of ectopia lentis, intellectual disability, skeletal abnormalities, elevated homocysteine levels, and CBS gene mutations align with a definitive diagnosis of homocystinuria.The patient is currently managed with a low-methionine diet supplemented with pyridoxine (vitamin B6), betaine, and folate to lower homocysteine levels.The patient's condition has been stabilized, and arrangements have been made for close follow-up to monitor homocysteine levels and adjust treatment as needed.16FemaleCaucasian"
    },
    "8860": {
        "explanation_text": "Lactose intolerance, unspecified.",
        "symptom_text": "The patient has a history of recurrent gastrointestinal symptoms, including bloating, diarrhea, and abdominal pain, especially after consuming dairy products.The patient presents with bloating, diarrhea, and abdominal pain following the ingestion of lactose-containing foods.Lactose intolerance test results indicate a significant increase in hydrogen levels after lactose consumption, confirming lactose malabsorption.Lactose intolerance, unspecified: Verbatim_EHR_quote_justifying_the_codeThe patient reports consistent symptoms of bloating, diarrhea, and abdominal pain after consuming dairy. Lactose intolerance test results are positive, indicating lactose malabsorption.The patient is advised to follow a lactose-free diet, avoiding dairy products and incorporating lactase supplements when needed.N/A35FemaleCaucasian"
    },
    "8861": {
        "explanation_text": "von Gierke disease.",
        "symptom_text": "The patient has a known medical history of von Gierke disease, a rare genetic disorder affecting glucose-6-phosphatase activity leading to glycogen accumulation in the liver and kidneys.The patient presents with hepatomegaly, doll-like facies, growth retardation, fasting hypoglycemia, lactic acidosis, hyperlipidemia, and hyperuricemia.Laboratory tests reveal elevated liver enzymes, hyperlipidemia, hyperuricemia, and metabolic acidosis.Von Gierke disease (ICD-10-CM code E7401): \"E7401 Glycogen storage disease, type I, von Gierke's disease - This is a rare genetic disorder characterized by deficient glucose-6-phosphatase activity resulting in severe fasting hypoglycemia, lactic acidosis, and hepatomegaly with renomegaly.\"The patient's physical examination is consistent with von Gierke disease, showing hepatomegaly and doll-like facies. The diagnostic tests confirm the presence of lactic acidosis, hyperlipidemia, and hyperuricemia, further supporting the diagnosis.The patient is started on a strict dietary regimen with frequent feedings to prevent fasting hypoglycemia. Monitoring of blood glucose levels and lipid profiles is initiated. Consultation with a genetic counselor is recommended.The patient's condition improved with the dietary and medical management provided. Discharge instructions include dietary restrictions, monitoring of blood glucose levels, and regular follow-up with the endocrinologist.8 years oldMaleCaucasian"
    },
    "8862": {
        "explanation_text": "Other disorders of intestinal carbohydrate absorption.",
        "symptom_text": "The patient has a history of recurrent bloating, flatulence, and diarrhea after consuming foods high in carbohydrates.The patient presents with chronic diarrhea, foul-smelling stools, and abdominal distension.Lactose hydrogen breath test showed a significant rise in hydrogen levels post-consumption of lactose, indicating carbohydrate malabsorption.Other disorders of intestinal carbohydrate absorption (ICD-10-CM code E7439) - The patient presents with chronic diarrhea, foul-smelling stools, and abdominal distension. Diagnostic tests confirm carbohydrate malabsorption.The patient reports avoiding dairy products due to symptoms. Physical examination reveals no signs of malnutrition or other nutritional deficiencies.The patient is advised to follow a low-carbohydrate diet. Lactase enzyme supplements are prescribed to aid in carbohydrate digestion.The patient responded well to dietary modifications and enzyme supplements. Discharged in stable condition with recommendations for follow-up with a dietitian.45FemaleCaucasian"
    },
    "8863": {
        "explanation_text": "Pure hypercholesterolemia, unspecified.",
        "symptom_text": "The patient has a history of high cholesterol levels documented in previous annual check-ups.The patient is asymptomatic and denies any chest pain, shortness of breath, or exercise intolerance.Recent lipid panel results show elevated total cholesterol and LDL levels with normal triglycerides.Pure hypercholesterolemia, unspecified. The patient presents with elevated total cholesterol and LDL levels without any other associated lipid abnormalities.The patient has no family history of early cardiovascular disease or genetic lipid disorders. Lifestyle modification and dietary changes recommended.Prescription of atorvastatin 20mg daily for cholesterol management. Follow-up lipid panel scheduled in 3 months.52FemaleCaucasian"
    },
    "8864": {
        "explanation_text": "Familial hypercholesterolemia.",
        "symptom_text": "The patient has a family history of early-onset cardiovascular disease.The patient is asymptomatic and has no physical complaints.Lipid profile shows markedly elevated LDL cholesterol levels of 250 mg/dL.Familial hypercholesterolemia (E7801) - The patient has markedly elevated LDL cholesterol levels and a family history of early-onset cardiovascular disease, indicating a diagnosis of Familial hypercholesterolemia.The patient's physical examination is unremarkable except for xanthomas on the Achilles tendons. Genetic testing is pending to confirm the diagnosis.The patient is started on a statin medication for cholesterol management and advised on lifestyle modifications.N/A46FemaleCaucasian"
    },
    "8865": {
        "explanation_text": "Pure hyperglyceridemia.",
        "symptom_text": "The patient has a history of obesity and a sedentary lifestyle.The patient is asymptomatic and denies any chest pain, shortness of breath, or palpitations.Fasting lipid panel revealed elevated triglyceride levels of 400 mg/dL with normal cholesterol levels.Pure hyperglyceridemiaPatient counseled on lifestyle modifications including a low-fat diet and increased physical activity.Prescribed omega-3 fatty acid supplements and scheduled a follow-up lipid panel in 3 months.The patient was discharged in stable condition with instructions to follow up with the primary care physician for further management.45FemaleCaucasian"
    },
    "8866": {
        "explanation_text": "Mixed hyperlipidemia.",
        "symptom_text": "The patient has a history of obesity, sedentary lifestyle, and a family history of hyperlipidemia.The patient is asymptomatic and denies any chest pain, shortness of breath, or palpitations.Lipid panel results show elevated levels of both cholesterol and triglycerides.Mixed hyperlipidemia (E782): The patient presents with elevated levels of both cholesterol and triglycerides, meeting the criteria for a diagnosis of mixed hyperlipidemia.The patient has been advised to start a low-fat diet, increase physical activity, and begin statin therapy.The patient was prescribed atorvastatin 20mg daily and referred to a nutritionist for dietary counseling.The patient was discharged in stable condition with a follow-up appointment scheduled in two weeks.55FemaleCaucasian"
    },
    "8867": {
        "explanation_text": "Other hyperlipidemia.",
        "symptom_text": "The patient has a history of obesity and a sedentary lifestyle.The patient complains of occasional chest discomfort and fatigue.Lab results show elevated total cholesterol and triglyceride levels.Other hyperlipidemia without mention of atherosclerosisThe patient has elevated lipid levels without evidence of atherosclerosis. Advised lifestyle modifications and follow-up lipid profile.Prescribed statin therapy and recommended dietary changes.The patient was discharged in stable condition with a plan for outpatient lipid monitoring.52FemaleCaucasian"
    },
    "8868": {
        "explanation_text": "Hyperlipidemia, unspecified.",
        "symptom_text": "The patient has a history of obesity and a sedentary lifestyle.The patient is asymptomatic and denies any chest pain, shortness of breath, or peripheral edema.Lipid panel results show elevated total cholesterol and triglycerides.Hyperlipidemia, unspecified. Verbatim copy of the ICD_10_CM's verbatim_EHR_quote_justifying_the_code field here.Patient counseled on lifestyle modifications, including dietary changes and increased physical activity.Prescribed atorvastatin 20mg daily to manage lipid levels.55FemaleCaucasian"
    },
    "8869": {
        "explanation_text": "Gilbert syndrome.",
        "symptom_text": "The patient has a history of intermittent jaundice without any evidence of liver disease or hemolysis.Intermittent yellowing of the skin and sclera, exacerbated by fasting and stress, but no other significant symptoms.Liver function tests consistently show unconjugated hyperbilirubinemia with normal levels of other liver enzymes.Gilbert syndrome (ICD-10-CM code E804) - 'Unconjugated hyperbilirubinemia due to a deficiency in hepatic bilirubin glucuronidation.'The patient presents with a history of intermittent jaundice since adolescence, triggered by fasting and stress. Physical examination reveals yellow discoloration of the skin and sclera without signs of acute illness. Liver function tests confirm unconjugated hyperbilirubinemia with normal levels of other liver enzymes, consistent with Gilbert syndrome.No specific treatment is required for Gilbert syndrome. Reassurance and lifestyle modifications to avoid triggers are recommended.The patient's symptoms are consistent with a benign course of Gilbert syndrome. Discharge instructions include avoiding prolonged fasting and managing stress to minimize episodes of jaundice.28MaleCaucasian"
    },
    "8870": {
        "explanation_text": "Other disorders of bilirubin metabolism.",
        "symptom_text": "The patient has a history of intermittent episodes of jaundice and elevated bilirubin levels.The patient presents with yellowing of the skin and sclera, generalized weakness, and fatigue.Laboratory tests show elevated levels of unconjugated bilirubin and normal liver function tests.Other disorders of bilirubin metabolismThe patient's symptoms and diagnostic test results are consistent with a diagnosis of Other disorders of bilirubin metabolism. No evidence of hemolysis or liver pathology is noted.The patient is advised to follow a low-fat diet and to avoid medications metabolized by the liver. Follow-up blood tests are scheduled to monitor bilirubin levels.The patient's condition improved with conservative management, and they were discharged with instructions for outpatient follow-up.45FemaleCaucasian"
    },
    "8871": {
        "explanation_text": "Wilson's disease.",
        "symptom_text": "The patient, a 32-year-old Caucasian male, has a history of unexplained liver disease and tremors.The patient presents with jaundice, abdominal pain, tremors, and dysarthria.Laboratory tests revealed low serum ceruloplasmin levels and elevated hepatic copper content.Wilson's disease is a rare inherited disorder of copper metabolism characterized by hepatic and neurological symptoms. The diagnosis is supported by low serum ceruloplasmin levels and elevated hepatic copper content.The patient shows signs of hepatic dysfunction and neurological impairment consistent with Wilson's disease. Treatment with copper-chelating agents has been initiated.The patient is started on oral D-penicillamine to chelate excess copper and zinc acetate to inhibit copper absorption.The patient responded well to treatment and is advised to continue medication. Follow-up appointments are scheduled to monitor copper levels and adjust treatment as needed.32MaleCaucasian"
    },
    "8872": {
        "explanation_text": "Hereditary hemochromatosis.",
        "symptom_text": "The patient has a family history of hereditary hemochromatosis. No history of repeated red blood cell transfusions or other iron metabolism disorders.Complaints of fatigue, joint pain, and abdominal pain. No symptoms of hypercholesterolemia, hyperglyceridemia, hyperuricemia, or other mineral metabolism disorders.Serum iron levels are markedly elevated. Transferrin saturation is above 60%. Liver function tests show elevated serum ferritin levels. Genetic testing confirms the presence of the HFE gene mutation.Hereditary hemochromatosis (ICD-10-CM code E83110): The patient presents with fatigue, joint pain, abdominal pain, markedly elevated serum iron levels, transferrin saturation above 60%, elevated serum ferritin levels, and genetic confirmation of the HFE gene mutation.The patient's symptoms and diagnostic results are consistent with a diagnosis of hereditary hemochromatosis. No evidence of other iron metabolism disorders or conditions like hypercholesterolemia or hyperuricemia.Phlebotomy recommended to reduce iron levels. Dietary advice provided to limit iron intake. Follow-up genetic counseling scheduled.The patient responded well to phlebotomy treatments with a reduction in serum iron levels. Discharged with instructions for ongoing monitoring and management of hereditary hemochromatosis.45FemaleCaucasian"
    },
    "8873": {
        "explanation_text": "Hemochromatosis due to repeated red blood cell transfusions.",
        "symptom_text": "The patient has a history of chronic anemia requiring multiple red blood cell transfusions over the past five years.The patient presents with fatigue, joint pain, and bronze skin pigmentation.Serum iron studies reveal elevated ferritin levels and transferrin saturation.Hemochromatosis due to repeated red blood cell transfusions. The patient's symptoms and iron studies are consistent with secondary hemochromatosis resulting from repeated transfusions.The patient reports increased joint pain and fatigue despite adequate transfusion management. Physical examination shows signs of bronze skin pigmentation, indicative of iron overload.Initiated phlebotomy sessions to reduce iron levels and advised dietary modifications to limit iron intake.The patient responded well to treatment and was discharged with a plan for regular follow-ups to monitor iron levels and adjust treatment as needed.52FemaleCaucasian"
    },
    "8874": {
        "explanation_text": "Other hemochromatosis.",
        "symptom_text": "The patient has a history of joint pain and heart palpitations.The patient presents with fatigue, joint pain, and heart palpitations.Laboratory results show elevated serum ferritin levels of 450 ng/mL and transferrin saturation of 50%. Genetic testing revealed mutations in the TFR2 gene.Other hemochromatosis (E83118): The patient presents with fatigue, joint pain, and heart palpitations. Laboratory results show elevated serum ferritin levels of 450 ng/mL and transferrin saturation of 50%. Genetic testing revealed mutations in the TFR2 gene.The patient reports increased fatigue over the past few months. Joint pain is localized to the wrists and knees and is worse in the mornings. Cardiac evaluation is pending.The patient is advised to undergo therapeutic phlebotomy to reduce iron overload. Follow-up genetic counseling is recommended.The patient responded well to phlebotomy and is scheduled for regular follow-up visits with the hematologist.45FemaleCaucasian"
    },
    "8875": {
        "explanation_text": "Hemochromatosis, unspecified.",
        "symptom_text": "The patient has a history of chronic liver disease and diabetes mellitus type 2.The patient presents with joint pain, fatigue, and abdominal discomfort.Lab results show elevated serum iron levels, increased ferritin, and high transferrin saturation.Hemochromatosis, unspecified (ICD-10-CM code E83119): The patient presents with joint pain, fatigue, and abdominal discomfort along with elevated serum iron levels, increased ferritin, and high transferrin saturation.The patient reports a family history of hemochromatosis. Physical examination reveals hepatomegaly and skin pigmentation changes.The patient is advised to undergo therapeutic phlebotomy to reduce iron levels.The patient responded well to treatment and was discharged in stable condition.55MaleCaucasian"
    },
    "8876": {
        "explanation_text": "Hypocalcemia.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3, parathyroidectomy due to primary hyperparathyroidism, and vitamin D deficiency.The patient presents with tingling sensations in the extremities, muscle cramps, and a positive Chvostek sign.Laboratory results indicate low total serum calcium levels of 7.8 mg/dL (normal range: 8.5-10.5 mg/dL) and low ionized calcium levels of 3.8 mg/dL (normal range: 4.6-5.3 mg/dL). Vitamin D levels are within normal limits.Hypocalcemia (ICD-10-CM code E8351): The patient presents with low total serum calcium levels of 7.8 mg/dL and ionized calcium levels of 3.8 mg/dL, along with symptoms of tingling sensations, muscle cramps, and a positive Chvostek sign.The patient's hypocalcemia is likely secondary to the history of parathyroidectomy and chronic kidney disease. Calcium and vitamin D supplementation has been initiated.The patient is started on oral calcium carbonate and calcitriol supplementation. Close monitoring of calcium levels and renal function is recommended.The patient's symptoms of tingling sensations and muscle cramps have improved with calcium supplementation. Discharge instructions include continuing the prescribed medications and follow-up with the endocrinologist in two weeks.55FemaleCaucasian"
    },
    "8877": {
        "explanation_text": "Hypercalcemia.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 due to hypertension. No history of cystic fibrosis, amyloidosis, or disorders of iron metabolism.The patient presented with fatigue, constipation, and frequent urination.Laboratory tests revealed elevated serum calcium levels of 12.2 mg/dL (normal range: 8.5-10.2 mg/dL). Serum phosphorus, magnesium, and iron levels were within normal limits.Hypercalcemia due to underlying chronic kidney disease: The patient presents with elevated serum calcium levels of 12.2 mg/dL (normal range: 8.5-10.2 mg/dL) in the setting of chronic kidney disease stage 3.The patient's symptoms of fatigue, constipation, and frequent urination are consistent with hypercalcemia. The elevated serum calcium levels are indicative of the diagnosis. No signs of hypocalcemia or other mineral metabolism disorders observed.The patient was advised to increase fluid intake, avoid calcium-rich foods, and prescribed calcitonin for symptomatic relief. Close monitoring of serum calcium levels recommended.The patient's symptoms improved with treatment, and serum calcium levels decreased to 10.1 mg/dL at discharge. Follow-up with the nephrologist advised for ongoing management of chronic kidney disease and hypercalcemia.65FemaleCaucasian"
    },
    "8878": {
        "explanation_text": "Other disorders of calcium metabolism.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 due to hypertension, which has been stable with medical management. No history of hemochromatosis, cystic fibrosis, amyloidosis, dehydration, or volume depletion.The patient presented with fatigue, muscle weakness, and tingling sensations in the fingers, which prompted further evaluation.Laboratory tests revealed low serum calcium levels (8.2 mg/dL) and elevated parathyroid hormone levels (85 pg/mL). Vitamin D levels were within normal limits. Renal function tests showed stable kidney function.Other disorders of calcium metabolism (E8359): \"Other disorders of calcium metabolism\"The patient's symptoms of fatigue, muscle weakness, and tingling, coupled with low serum calcium levels and elevated parathyroid hormone levels, are consistent with a diagnosis of Other disorders of calcium metabolism. No evidence of hemochromatosis, phosphorus metabolism disorders, magnesium disorders, or amyloidosis.The patient was started on oral calcium supplements and advised on dietary changes to improve calcium absorption. Follow-up in 2 weeks for reassessment of symptoms and repeat labs.The patient responded well to treatment, with symptomatic improvement noted at discharge. Close outpatient follow-up is recommended to monitor calcium levels and adjust treatment as needed.62FemaleCaucasian"
    },
    "8879": {
        "explanation_text": "Other disorders of mineral metabolism.",
        "symptom_text": "The patient has a history of recurrent kidney stones and osteoporosis.The patient presents with fatigue, bone pain, and muscle weakness.Laboratory tests show elevated levels of parathyroid hormone (PTH) and low bone mineral density on DEXA scan.Other disorders of mineral metabolism (ICD-10-CM code E8389): The patient presents with fatigue, bone pain, and muscle weakness. Laboratory tests show elevated PTH levels and low bone mineral density on DEXA scan.The patient reports a history of recurrent kidney stones and osteoporosis. Physical examination reveals tenderness over bony prominences.The patient is advised to increase dietary calcium intake, start vitamin D supplementation, and undergo further evaluation by an endocrinologist.The patient was discharged in stable condition with a follow-up appointment scheduled with the endocrinologist.58FemaleCaucasian"
    },
    "8880": {
        "explanation_text": "Disorder of mineral metabolism, unspecified.",
        "symptom_text": "The patient has a history of recurrent kidney stones and a family history of unspecified mineral metabolism disorders.The patient presented with generalized weakness and fatigue, without any specific signs of iron, calcium, or other mineral imbalances.Serum electrolyte panel showed no abnormalities in calcium, phosphorus, magnesium, or other mineral levels.Disorder of mineral metabolism, unspecifiedThe patient's symptoms and lab results are consistent with a generic mineral metabolism disorder without specific derangements in iron, calcium, or other mineral levels.The patient was advised to increase fluid intake and follow up for regular electrolyte monitoring.The patient's symptoms improved with hydration, and no acute interventions were required for the mineral metabolism disorder.45FemaleCaucasian"
    },
    "8881": {
        "explanation_text": "Cystic fibrosis with pulmonary manifestations.",
        "symptom_text": "The patient has a history of recurrent respiratory infections, chronic cough, and sputum production.The patient presents with symptoms of increased dyspnea on exertion, frequent lung congestion, and digital clubbing.Sweat chloride test results showed elevated levels consistent with cystic fibrosis. Chest X-ray revealed bronchiectasis and hyperinflation.Cystic fibrosis with pulmonary manifestations. Verbatim ICD-10-CM quote: 'Cystic fibrosis with pulmonary manifestations'The patient's pulmonary function tests indicate obstructive pattern consistent with cystic fibrosis. The patient has a history of multiple hospital admissions due to pulmonary exacerbations.Treatment includes inhaled bronchodilators, chest physiotherapy, and long-term antibiotics for chronic Pseudomonas aeruginosa infection.The patient responded well to treatment and was discharged with instructions for airway clearance techniques and follow-up with the pulmonology clinic in two weeks.24MaleCaucasian"
    },
    "8882": {
        "explanation_text": "Cystic fibrosis, unspecified.",
        "symptom_text": "The patient has a history of recurrent respiratory infections, failure to thrive, and pancreatic insufficiency.The patient presents with chronic cough, wheezing, and frequent episodes of shortness of breath.Sweat chloride test results indicate elevated levels consistent with Cystic fibrosis. Genetic testing confirmed the presence of CFTR gene mutations.Cystic fibrosis, unspecified. Verbatim EHR quote justifying the code: 'The patient's symptoms, along with elevated sweat chloride levels and genetic testing confirming CFTR gene mutations, are consistent with a diagnosis of Cystic fibrosis.'The patient shows signs of malnutrition, digital clubbing, and decreased pulmonary function on spirometry.Treatment includes pancreatic enzyme replacement therapy, chest physiotherapy, inhaled bronchodilators, and nutritional supplementation.The patient responded well to treatment and was discharged with a plan for regular follow-up appointments with the pulmonology and gastroenterology departments.22FemaleCaucasian"
    },
    "8883": {
        "explanation_text": "Organ-limited amyloidosis.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3 due to hypertension. No history of cystic fibrosis, mineral metabolism disorders, or other amyloidosis.The patient presents with proteinuria, edema in lower extremities, and fatigue. No symptoms of dehydration, electrolyte imbalances, or acid-base disturbances.Serum and urine protein electrophoresis show the presence of amyloid protein. Renal biopsy confirms amyloid deposits in the kidney.Organ-limited amyloidosis (E854): Amyloidosis of the kidney.The patient's renal function is stable, and there are no signs of systemic amyloidosis affecting other organs. The patient is not dehydrated and has no electrolyte imbalances.Treatment with angiotensin-converting enzyme inhibitors to manage proteinuria and blood pressure. Follow-up with a nephrologist for monitoring kidney function.The patient was discharged in stable condition with close follow-up recommended to monitor kidney function and amyloidosis progression.68FemaleCaucasian"
    },
    "8884": {
        "explanation_text": "Other amyloidosis.",
        "symptom_text": "The patient has a history of proteinuria and unexplained weight loss over the past few months.The patient presents with fatigue, peripheral edema, and proteinuria.Serum and urine protein electrophoresis show abnormal protein deposits consistent with amyloidosis. Kidney biopsy confirms the presence of amyloid deposits.Other amyloidosis (E8589): The verbatim_EHR_quote_justifying_the_code will be included in this section.Physical exam reveals hepatomegaly and macroglossia, which are indicative of systemic amyloidosis. No signs of cystic fibrosis or specific electrolyte abnormalities are noted.The patient is started on colchicine for amyloidosis management and referred to a nephrologist for further evaluation.The patient responded well to treatment and is advised to follow up with the nephrologist for ongoing management of amyloidosis.62FemaleCaucasian"
    },
    "8885": {
        "explanation_text": "Dehydration.",
        "symptom_text": "The patient has a history of hypertension and is on a diuretic medication for the past year.The patient presents with dry mucous membranes, decreased skin turgor, tachycardia, and hypotension.Lab results indicate elevated BUN and creatinine levels.Dehydration (ICD-10-CM code E860): The patient is diagnosed with dehydration due to decreased fluid volume in the body. The symptoms and lab results are consistent with this diagnosis.The patient appears lethargic and has poor skin turgor. Vital signs show tachycardia and hypotension. Lab results support the diagnosis of dehydration.The patient was treated with intravenous fluids to rehydrate and improve fluid balance. Monitoring of electrolytes and renal function was initiated.The patient responded well to treatment and was discharged with instructions to increase fluid intake and follow up with their primary care physician.65FemaleCaucasian"
    },
    "8886": {
        "explanation_text": "Volume depletion, unspecified.",
        "symptom_text": "The patient has a history of recurrent episodes of excessive sweating and prolonged physical activity without adequate fluid intake.The patient presents with extreme thirst, dry mucous membranes, decreased urine output, and orthostatic hypotension.Laboratory tests show elevated blood urea nitrogen (BUN) and creatinine levels, indicating dehydration.Volume depletion, unspecified (ICD-10-CM code E869): The patient is diagnosed with volume depletion due to excessive fluid loss.The patient reports recent travel to a hot climate and engaging in strenuous outdoor activities without sufficient water intake. Physical examination reveals tachycardia and hypotension.The patient was treated with intravenous fluids to rehydrate and correct the volume depletion.The patient responded well to the treatment and was discharged with recommendations for adequate hydration and electrolyte balance maintenance.45FemaleCaucasian"
    },
    "8887": {
        "explanation_text": "Hyperosmolality and hypernatremia.",
        "symptom_text": "The patient has a history of uncontrolled diabetes mellitus and hypertension.The patient presents with extreme thirst, confusion, and generalized weakness.Lab results show increased serum osmolality and sodium levels.Hyperosmolality and hypernatremia. The patient's condition is consistent with the diagnosis of Hyperosmolality and hypernatremia (ICD-10-CM code E870) as evidenced by the extreme thirst, confusion, and increased serum osmolality and sodium levels.The patient's neurological symptoms are likely due to the electrolyte imbalance, and immediate intervention is necessary to correct the hypernatremia and hyperosmolality.Treatment includes intravenous fluid therapy with hypotonic solutions to normalize serum sodium levels and osmolality.The patient responded well to treatment and was discharged with instructions for close monitoring of electrolyte levels.58FemaleCaucasian"
    },
    "8888": {
        "explanation_text": "Hypo-osmolality and hyponatremia.",
        "symptom_text": "The patient has a history of heart failure and chronic kidney disease stage 3.The patient presents with confusion, weakness, and generalized swelling.Laboratory tests reveal serum osmolality of 260 mOsm/kg, serum sodium level of 125 mEq/L, and urine osmolality of 600 mOsm/kg.Hypo-osmolality and hyponatremia are present in this patient, leading to the primary diagnosis of E871 - Hypo-osmolality and hyponatremia (Include a verbatim copy of the ICD_10_CM's verbatim_EHR_quote_justifying_the_code field here.)The patient's confusion and weakness are consistent with the electrolyte imbalances observed. Treatment with fluid restriction and hypertonic saline infusion has been initiated.The patient is receiving treatment with fluid restriction and hypertonic saline infusion to correct the electrolyte imbalances.The patient's serum sodium levels have improved to 135 mEq/L, and the patient is stable for discharge.68MaleCaucasian"
    },
    "8889": {
        "explanation_text": "Mixed disorder of acid-base balance.",
        "symptom_text": "The patient has a history of hypertension and type 2 diabetes mellitus.The patient presents with confusion, lethargy, and mild tachypnea.Arterial blood gas analysis shows a pH of 7.35, bicarbonate level of 22 mEq/L, and a PCO2 of 30 mmHg.Mixed disorder of acid-base balance. Verbatim ICD-10-CM's verbatim_EHR_quote_justifying_the_code: 'Mixed disorder of acid-base balance presenting with a pH of 7.35, bicarbonate level of 22 mEq/L, and a PCO2 of 30 mmHg.'The patient's acid-base imbalance is consistent with a mixed disorder, likely due to a combination of respiratory alkalosis and metabolic acidosis.The patient was treated with intravenous fluids, correction of electrolyte imbalances, and monitoring of acid-base status.The patient's acid-base balance improved with treatment, and the patient was discharged home in stable condition.65FemaleCaucasian"
    },
    "8890": {
        "explanation_text": "Hyperkalemia.",
        "symptom_text": "The patient has a history of chronic kidney disease stage 3, hypertension, and heart failure.The patient presented with muscle weakness, palpitations, and mild confusion.Lab tests revealed serum potassium levels of 6.2 mEq/L.HyperkalemiaThe patient's ECG showed peaked T-waves consistent with hyperkalemia. No signs of metabolic acidosis were noted.The patient was treated with intravenous calcium gluconate, insulin-dextrose therapy, and oral sodium polystyrene sulfonate.The patient's potassium levels normalized, and symptoms resolved. Discharged in stable condition.65MaleCaucasian"
    },
    "8891": {
        "explanation_text": "Alpha-1-antitrypsin deficiency.",
        "symptom_text": "The patient has a family history of Alpha-1-antitrypsin deficiency. No other significant medical history present.The patient presents with dyspnea, chronic cough, and recurrent respiratory infections.Laboratory tests show low serum levels of Alpha-1-antitrypsin. Genetic testing confirms the presence of Alpha-1-antitrypsin deficiency.Alpha-1-antitrypsin deficiency (ICD-10-CM code E8801): The deficiency of Alpha-1-antitrypsin is confirmed by laboratory tests and genetic analysis.The patient has a long-standing history of respiratory symptoms consistent with Alpha-1-antitrypsin deficiency. No other significant findings on physical examination.The patient is started on augmentation therapy with Alpha-1-proteinase inhibitor. Smoking cessation counseling is provided.The patient is stable on treatment and discharged with instructions for follow-up pulmonary function tests and genetic counseling for family members.45FemaleCaucasian"
    },
    "8892": {
        "explanation_text": "Other disorders of plasma-protein metabolism, not elsewhere classified.",
        "symptom_text": "The patient has a history of plasma-protein metabolism disorders.The patient presents with edema, fatigue, and proteinuria.Laboratory tests show decreased levels of specific plasma proteins without electrolyte imbalances or acid-base disturbances.Other disorders of plasma-protein metabolism, not elsewhere classified. Verbatim EHR quote justifying the code: 'The patient is diagnosed with Other disorders of plasma-protein metabolism, not elsewhere classified based on the history of plasma-protein metabolism disorders and the current presentation of edema, fatigue, and proteinuria.'The patient's symptoms are consistent with a plasma-protein metabolism disorder. No signs of acid-base balance disorders, electrolyte imbalances, or other metabolic issues are noted.Treatment includes dietary modifications and close monitoring of protein levels.The patient responded well to treatment and was discharged with recommendations for follow-up monitoring of plasma protein levels.45FemaleCaucasian"
    },
    "8893": {
        "explanation_text": "Lipodystrophy, not elsewhere classified.",
        "symptom_text": "The patient has a history of lipodystrophy with atypical fat distribution and metabolic abnormalities.The patient presents with generalized loss of body fat, leading to abnormal fat accumulation in certain areas like the face, neck, and abdomen.Laboratory tests show dyslipidemia, insulin resistance, and fatty liver.Lipodystrophy, not elsewhere classified (E881): \"Lipodystrophy, not elsewhere classified, is a condition characterized by abnormal or degenerated adipose tissue distribution, leading to metabolic complications.\"The patient's physical examination reveals prominent musculature due to lack of subcutaneous fat in various body regions.Treatment includes dietary modifications, insulin sensitizers, and lipid-lowering agents to manage the metabolic consequences of lipodystrophy.The patient was discharged with a follow-up plan for ongoing management of lipodystrophy and its associated metabolic abnormalities.42FemaleCaucasian"
    },
    "8894": {
        "explanation_text": "Lipomatosis, not elsewhere classified.",
        "symptom_text": "The patient has a history of gradual, painless development of multiple soft, rubbery, mobile masses under the skin, consistent with Lipomatosis.The patient denies any symptoms such as electrolyte imbalances, fluid overload, acid-base disturbances, or metabolic abnormalities. There are no associated symptoms such as muscle weakness, weight loss, or endocrine abnormalities.Ultrasound imaging shows multiple subcutaneous adipose tissue deposits consistent with Lipomatosis. No abnormalities in electrolyte levels, acid-base balance, or plasma-protein metabolism are noted.Lipomatosis, not elsewhere classified. Verbatim EHR quote justifying the code: 'The patient presents with multiple painless subcutaneous masses, characteristic of Lipomatosis.'On examination, the masses are non-tender, soft, and freely movable under the skin, typical of Lipomatosis. No signs of fluid overload, electrolyte imbalances, or metabolic disturbances are observed.The patient is reassured about the benign nature of Lipomatosis. Surgical excision is discussed for symptomatic or cosmetically concerning lipomas.The patient is discharged with instructions for regular follow-up to monitor the size and symptoms of the lipomas.54FemaleCaucasian"
    },
    "8895": {
        "explanation_text": "Tumor lysis syndrome.",
        "symptom_text": "The patient is a 52-year-old male with a recent diagnosis of Burkitt lymphoma undergoing chemotherapy.The patient presented with weakness, fatigue, nausea, and oliguria.Laboratory findings showed hyperkalemia (potassium 6.5 mEq/L), hyperphosphatemia (phosphate 7.0 mg/dL), hypocalcemia (calcium 7.8 mg/dL), and hyperuricemia (uric acid 12 mg/dL).Tumor lysis syndrome (ICD-10-CM code E883): The patient developed acute renal failure due to the rapid breakdown of cancer cells, leading to electrolyte imbalances including hyperkalemia, hyperphosphatemia, hypocalcemia, and hyperuricemia.The patient's electrolyte imbalances were consistent with tumor lysis syndrome, requiring urgent intervention to prevent further renal damage.The patient was treated with aggressive hydration, allopurinol, rasburicase, and initiated on continuous renal replacement therapy.The patient showed improvement in renal function and electrolyte levels with treatment and was discharged with close follow-up for chemotherapy cycles.52MaleNot specified"
    },
    "8896": {
        "explanation_text": "Mitochondrial metabolism disorder, unspecified.",
        "symptom_text": "The patient has a history of chronic fatigue, exercise intolerance, and muscle weakness.The patient presents with fatigue, muscle pain, and gastrointestinal issues.Mitochondrial function tests show impaired oxidative phosphorylation.Mitochondrial metabolism disorder, unspecified. Verbatim EHR quote justifying the code: 'The patient presents with a history of chronic fatigue, exercise intolerance, and muscle weakness. Diagnostic tests revealed impaired oxidative phosphorylation, consistent with a mitochondrial metabolism disorder.'The patient's symptoms and test results are indicative of a mitochondrial disorder. No evidence of hypokalemia, fluid overload, or other electrolyte imbalances observed.Initiated treatment with Coenzyme Q10 supplementation and physical therapy.The patient responded well to treatment and was discharged with instructions for follow-up mitochondrial function testing in three months.45FemaleCaucasian"
    },
    "8897": {
        "explanation_text": "MELAS syndrome.",
        "symptom_text": "The patient has a history of recurrent stroke-like episodes, seizures, developmental delays, and exercise intolerance.Presented with severe headaches, visual disturbances, muscle weakness, and fatigue.MRI showing characteristic changes in the brain consistent with MELAS syndrome. Elevated lactate levels in the blood.MELAS syndrome (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes syndrome) (E8841)The patient's clinical presentation, including the history of stroke-like episodes, elevated lactate levels, and characteristic MRI findings, align with a diagnosis of MELAS syndrome.Started on a regimen of Coenzyme Q10 and L-arginine to improve mitochondrial function. Physical therapy initiated to help with muscle weakness.The patient showed improvement in symptoms with the treatment provided and was discharged with a follow-up scheduled in two weeks.23FemaleCaucasian"
    },
    "8898": {
        "explanation_text": "Postprocedural hypothyroidism.",
        "symptom_text": "The patient, a 45-year-old female, has a history of multinodular goiter and underwent a total thyroidectomy two weeks ago.The patient presents with fatigue, weight gain, cold intolerance, and dry skin.TSH levels are elevated at 12 mIU/L, and free T4 levels are decreased at 0.8 ng/dL.Postprocedural hypothyroidismPatient's symptoms and lab results are consistent with postprocedural hypothyroidism following the recent thyroidectomy.Started on levothyroxine 50 mcg daily.Patient discharged in stable condition with close follow-up for thyroid function tests in two weeks.45FemaleCaucasian"
    },
    "8899": {
        "explanation_text": "Postprocedural hypoinsulinemia.",
        "symptom_text": "The patient has a history of type 2 diabetes mellitus controlled with oral antidiabetic medications.The patient presented with sweating, palpitations, and confusion post-surgery.Blood tests revealed low insulin levels with normal blood glucose.Postprocedural hypoinsulinemia. The patient developed sweating, palpitations, and confusion post-surgery, with low insulin levels in the blood, indicative of hypoinsulinemia.The patient's symptoms are consistent with hypoinsulinemia post-surgery. Recommend close monitoring of blood glucose levels and insulin therapy.Started on insulin therapy to manage hypoinsulinemia. Educated the patient on self-monitoring of blood glucose levels.Patient responded well to insulin therapy and education on self-monitoring of blood glucose levels. Discharged in stable condition with instructions to follow up with the endocrinologist for further management.58FemaleCaucasian"
    }
}